| Pediatric-Type Diffuse Low-Grade Glioma studied in …STUDIED_INderived10 of 43show all (up to 200) |
|---|
| → studied in | NCT06047379Phase 1/Phase 2 · recruiting Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis · condition mapped ALIAS · 43 trials mapped (15 active) | — | — | Astrocytoma, IDH-Mutant, Grade 2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04729959Phase 2 · active not recruiting Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 43 trials mapped (15 active) | — | — | Diffuse Astrocytoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03528642Phase 1 · active not recruiting Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma · condition mapped ONTOLOGY_EXACT · 43 trials mapped (15 active) | — | — | Astrocytoma, IDH-Mutant, Grade 2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07703436Phase 2 · not yet recruiting Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease · condition mapped ONTOLOGY_EXACT · 43 trials mapped (15 active) | — | — | Astrocytoma, IDH-Mutant, Grade 2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04065776NA · active not recruiting Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma · condition mapped CURATED_BROADER · 43 trials mapped (15 active) | — | — | Diffuse Astrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06860594Phase 1 · recruiting Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma · condition mapped ONTOLOGY_EXACT · 43 trials mapped (15 active) | — | — | Astrocytoma, IDH-Mutant, Grade 2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05303519Phase 3 · recruiting SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) · condition mapped ONTOLOGY_EXACT · 43 trials mapped (15 active) | — | — | Astrocytoma, IDH-Mutant, Grade 2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03975829Phase 4 · active not recruiting Pediatric Long-Term Follow-up and Rollover Study · condition mapped CURATED_BROADER · 43 trials mapped (15 active) | — | — | Diffuse Astrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03180502Phase 2 · active not recruiting Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma · condition mapped CURATED_BROADER · 43 trials mapped (15 active) | — | — | Diffuse Astrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07712757Phase 3 · not yet recruiting Safety and Efficacy Study of Safusidenib in Participants With Grade 2 IDH1-Mutant Glioma · condition mapped ONTOLOGY_EXACT · 43 trials mapped (15 active) | — | — | Astrocytoma, IDH-Mutant, Grade 2 | 1 | Observed | clinicaltrials | graph → |